School of Medicine
Showing 1-77 of 77 Results
-
Meysam Dadgar
Postdoctoral Scholar, Molecular Imaging Program at Stanford
BioMeysam Dadgar is a Postdoctoral Research Fellow at the Molecular Imaging Program at Stanford, School of Medicine. He obtained his Ph.D. in Biophysics as part of the J-PET collaboration at Jagiellonian University in Kraków, Poland. His research focuses on the development and optimization of advanced PET imaging systems for early cancer detection, integrating state-of-the-art medical imaging technologies, signal processing, and AI-based image enhancement techniques to improve diagnostic accuracy and patient outcomes.
-
Eduardo De la Vega
Postdoctoral Scholar, Epidemiology
Current Research and Scholarly InterestsMy research aims to identify key barriers adolescents face and explore how affected communities can actively mobilize for change. I aim to investigate how adolescents and community members can identify environmental hazards, propose practical solutions, and effectively advocate for policy changes by engaging directly with decision-makers and leveraging technological tools to amplify their voices and drive meaningful improvements in their environments.
-
Maharshi Krishna Deb
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsI aim to gain insights of the molecular underpinnings that are critical for the specification of human germ cells as well as the episode of epigenetic reprogramming that they undergo which is critical for their development and thereby essential for perpetual propagation of human species. Under co-mentorship of Prof. Azim Surani and Dr. Shiv Grewal,I aim to learn these lessons from this immortal lineage of human germline to identify interventions against various pediatric as well as degenerative
-
Boxiong Deng
Postdoctoral Scholar, Ophthalmology
BioBoxiong Currently is a postdoctoral fellow in Dr. Sui Wang's lab within Stanford University's Department of Ophathalmology, focusing on the interplay between retinal Müller glial cells and the vasculature in diabetic conditions.
-
Dr. Qiwen Deng
Postdoctoral Scholar, Pathology
BioHow fibroblasts participate in the organ fibrosis and whether targeting fibroblasts is a good strategy to reverse fibrosis is still a mystery. We have identified two important immune checkpoints, CD47 and PD-L1, are highly expressed in fibroblasts and blocking CD47 and PD-L1 reversed lung fibrosis. This is a prove of concept that targeting immune regulatory pathways could be an effective therapeutic approach to treat fibrotic diseases. In addition to identifying novel targets for the treatment of fibrosis, I am also interested in the crosstalk between fibroblasts and innate immune cells in the development of fibrosis. Combined with cutting-edge NGS approaches including single cell sequencing, spatial transcriptomics and high-dimensional CyTOF technique, we have identified several potential targets and characterized immune cells landscape in lung fibrosis. In the long run, I will focus on the validation of these targets. Specifically, I will apply gain- and loss-function approaches to investigate their role in fibrosis in vitro and in vivo.
-
Mariame D. Diabate, PhD
Postdoctoral Scholar, Epidemiology
BioMariame Diabate, PhD (she/her) is a postdoctoral scholar in the HIPE Lab (Healthcare Innovation, Policy and Equity), mentored by Dr. Alyce S. Adams in the Stanford Cancer Institute and the Departments of Health Policy/Epidemiology and Population Health, and Pediatrics (by courtesy) and Dr. Tainayah Thomas in the Department of Epidemiology and Population Health. A two-time Buckeye, she earned her PhD in Biomedical Sciences and BS in Biology with a minor in Global Public Health from The Ohio State University. Dr. Diabate uses bioinformatics to study breast and ovarian cancer variants, intending to reduce cancer treatment disparities for minority women.
Through her postdoctoral training, she aims to address the genetic, social, and policy drivers of persistent health disparities. Dr. Diabate is currently focused on integrating community perspectives into observational research to improve population health outcomes and influence health policy. Additionally, she applies AI technology to support better treatment decisions, working alongside interdisciplinary teams to close the gap between cancer research and marginalized communities, while advocating for equitable healthcare.
Previously, she served as the youngest state-level commissioner on Ohio’s New African Immigrant Commission and interned with UNAIDS in Geneva, Switzerland. Currently, Dr. Diabate is one of the co-presidents for Stanford’s Black Postdoctoral Association. Her passion for improving minority women's health continues to drive her research and advocacy. -
Xiruo Ding
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioI am a postdoctoral scholar at Stanford University, advised by Dr. Nima Aghaeepour, focusing on EHR-related modeling and phenotyping. My research interests lie in the application of general machine learning and deep learning methods to enhance healthcare outcomes.
-
Abdoul Jalil Djiberou Mahamadou
Postdoctoral Scholar, Biomedical Ethics
Current Research and Scholarly InterestsIdentify ethical, legal, and social considerations arising in the context of AI in the drug discovery process.
-
Can Dong
Postdoctoral Scholar, Neurobiology
BioMy research focuses on the cognitive mechanisms underpinning learning and memory and asks the following questions: 1) What are the neural bases for flexible coding of the brain and how do experiences shape these processes? 2) How do cross-brain-region activities influence memory encoding and recall? 3) Develop new techniques/methods to reintroduce the normal activity in the malfunctioned brains.
Durin my postdoc, I will work on spatial and social memory integration in the hippocampus to understand the mechanism of flexible coding in healthy and diseased brains. -
Chunyang Dong
Postdoctoral Scholar, Psychiatry
BioChunyang Dong completed his Ph.D. studies from University of California, Davis with Dr. Lin Tian, where he specialized in protein engineering to develop genetically encoded biosensors to enable real-time imaging of neuromodulator dynamics. As part of his postdoctoral pursuits with Dr. Sergiu Pasca at Stanford University, he hopes to combine disciplines between biosensors and modeling human neurological disease using brain region-specific organoids. Despite this shift, his unwavering goal is to deepen the understanding of brain development, disease processes, and translate research to potential treatments for neurological disorders.
-
Igor D. Bandeira
Postdoctoral Scholar, Psychiatry
BioIgor D. Bandeira, M.D., Ph.D., is a Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University. With extensive experience in interventional psychiatry, Dr. Bandeira has led multiple clinical trials focused on noninvasive brain stimulation and rapid-acting antidepressants for psychiatric disorders in children, adolescents, and adults. He received the prestigious Professor Alfredo Thomé de Britto Award in recognition of his exceptional research achievements during his physician-scientist training at the Federal University of Bahia in Salvador, Brazil.
As part of his medical training, Dr. Bandeira also studied at the University of Sydney (Australia) on a Science Without Borders Scholarship, where he enhanced his clinical and research skills at the university’s Brain and Mind Centre. Upon returning to Brazil, he gained valuable clinical experience as an attending physician with the Brazilian Ministry of Health and worked on the frontlines during the COVID-19 pandemic.
At Stanford, working with Dr. Nolan R. Williams, Dr. Bandeira led the Wellcome LEAP trial on accelerated intermittent theta-burst stimulation (Stanford Neuromodulation Therapy) to treat anhedonic depression. Alongside Dr. Alan F. Schatzberg, he is co-leading a trial supported by the American Foundation for Suicide Prevention, evaluating the efficacy and safety of buprenorphine in sustaining the antisuicidal and antidepressant effects of ketamine. His work centers on developing personalized therapeutics for treatment-resistant depression, bipolar depression, and suicidal behavior.
Looking ahead, Dr. Bandeira plans to apply for psychiatry residency programs in the United States to advance his career in academic psychiatry and clinical research. -
Luca Ducoli
Postdoctoral Scholar, Dermatology
BioI am an RNA biologist specializing in developing innovative experimental and computational methods to elucidate how RNA and proteins interact to regulate diverse aspects of cell biology. My research leverages cutting-edge approaches to uncover the molecular mechanisms by which RNA-binding proteins and long noncoding RNAs (lncRNAs) influence tissue homeostasis, with a particular focus on their roles in disease processes such as cancer and autoimmune disorders.
Currently, in Paul Khavari’s laboratories, I investigate how RNA-binding proteins and lncRNAs modulate gene expression and cellular responses, aiming to identify new regulatory pathways and potentially new therapeutic targets. My work contributes to the lab’s broader mission of understanding genome regulation and innovating genetic models to study human health and disease, especially in the context of epithelial biology. -
Ramzi Emanuel Dudum
Masters Student in Health Policy, admitted Autumn 2022
BioDr. Dudum is a cardiologist and population health expert working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University.
He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.
He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health expert, he leads efforts in the preventive cardiology section related to improving cardiovascular health.
